← All Sponsors
SPONSOR

InnoPharmax Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Biliary Tract Cancer
NCT05065957 Phase 2, Phase 3
Recruiting

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

Biliary Tract Cancer
Taiwan View Trial →